Home

mostantól jelölje be sada the overall survival was clearly vihar kiéhezett Mindent megteszek az erőmmel

A prognostic model for overall survival of patients with early-stage  non-small cell lung cancer: a multicentre, retrospective study - The Lancet  Digital Health
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health

A Novel Nomogram Predicting the Overall Survival of Patients with  Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based  Investigation | SpringerLink
A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink

Oncotarget: Identification intermediate-risk | EurekAlert!
Oncotarget: Identification intermediate-risk | EurekAlert!

ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year  Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with  Advanced RCC
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC

Kaplan–Meier curves showing recurrence-free survival and overall... |  Download Scientific Diagram
Kaplan–Meier curves showing recurrence-free survival and overall... | Download Scientific Diagram

Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a  Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell  Renal Cell Carcinoma | Anticancer Research
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma | Anticancer Research

ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year  Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with  Advanced RCC
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC

Six RNA binding proteins (RBPs) related prognostic model predicts overall  survival for clear cell renal cell carcinoma and is associated with immune  infiltration | Biomolecules and Biomedicine
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine

ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2)  for Metastatic Clear Cell RCC in Patients Treated With First-Line  Immunotherapy Combinations
ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations

Overall survival vs immunohistochemistry. The Kaplan Meier graph... |  Download Scientific Diagram
Overall survival vs immunohistochemistry. The Kaplan Meier graph... | Download Scientific Diagram

Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival  in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors  (099) - ScienceDirect
Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect

Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer

A Molecular Model for Predicting Overall Survival in Patients with  Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)  - eBioMedicine
A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance) - eBioMedicine

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer |  NEJM
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM

Prognosis of ovarian clear cell cancer compared with other epithelial  cancer types: A population‑based analysis
Prognosis of ovarian clear cell cancer compared with other epithelial cancer types: A population‑based analysis

Clear cell carcinoma of the ovary: a retrospective multicentre experience  of 254 patients with complete surgical staging | British Journal of Cancer
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging | British Journal of Cancer

Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and  Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with  Retroperitoneal Metastases
Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases

IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by  pyrosequencing | World Journal of Surgical Oncology | Full Text
IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing | World Journal of Surgical Oncology | Full Text

Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download  Scientific Diagram
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram

Cancers | Free Full-Text | COL7A1 Expression Improves Prognosis Prediction  for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage
Cancers | Free Full-Text | COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage

Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma  as determined by bioinformatics analysis
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis

BioCentury - The latest twist in the overall survival debate
BioCentury - The latest twist in the overall survival debate

Frontline Therapy in Advanced Clear Cell RCC: The CLEAR Trial
Frontline Therapy in Advanced Clear Cell RCC: The CLEAR Trial

A real-world 1:1 propensity-matched study revealed unmarried status was  independently associated with worse survival for patients with renal clear  cell carcinoma
A real-world 1:1 propensity-matched study revealed unmarried status was independently associated with worse survival for patients with renal clear cell carcinoma

Prognostic value of epithelial-mesenchymal transition markers in clear cell  renal cell carcinoma - Figure f3 | Aging
Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma - Figure f3 | Aging

Prognostic Value of Serum CA9 in Patients with Metastatic Clear Cell Renal  Cell Carcinoma under Targeted Therapy | Anticancer Research
Prognostic Value of Serum CA9 in Patients with Metastatic Clear Cell Renal Cell Carcinoma under Targeted Therapy | Anticancer Research

Current Oncology | Free Full-Text | Population-Based Survival Analysis of  Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major  Histological Subtypes of Cervical Cancer
Current Oncology | Free Full-Text | Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer

MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN  RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology
MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology